Infection and Immunity, March 2000, p. 1600-1607, Vol. 68, No. 3
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


Max-Planck-Institut für Immunbiologie, D-79108 Freiburg,1 and Klinik und Poliklinik für Innere Medizin III, Forschungslabor, D-06097 Halle (Saale),2 Germany
Received 22 July 1999/Returned for modification 20 September 1999/Accepted 22 November 1999
| |
ABSTRACT |
|---|
|
|
|---|
We investigated the reason for the inability of lipopolysaccharide
(LPS)-resistant (Lps-defective
[Lpsd]) C57BL/10ScCr mice to produce beta
interferon (IFN-
) when stimulated with bacteria. For this purpose,
the IFN-
and other macrophage cytokine responses induced by LPS and
several killed gram-negative and gram-positive bacteria in
LPS-sensitive (Lps-normal [Lpsn];
C57BL/10ScSn and BALB/c) and Lpsd (C57BL/10ScCr
and BALB/c/l) mice in vitro and in vivo were investigated on the mRNA
and protein levels. In addition, double-stranded RNA (dsRNA) was used
as a nonbacterial stimulus. LPS and all gram-negative bacteria employed
induced IFN-
in the Lpsn mice but not in the
Lpsd mice. All gram-positive bacteria tested
failed to induce significant amounts of IFN-
in all four of the
mouse strains used. As expected, all other cytokines tested (tumor
necrosis factor alpha, interleukin 1
[IL-1
], IL-6, and IL-10)
were differentially induced by gram-negative and gram-positive
bacteria. Stimulation with dsRNA induced IFN-
and all other
cytokines mentioned above in all mouse strains, regardless of their LPS
sensitivities. The results suggest strongly that LPS is the only
bacterial component capable of inducing IFN-
in significant amounts
that are readily detectable under the conditions used in this study.
Consequently, in mice, IFN-
is inducible only by gram-negative
bacteria, but not in C57BL/10ScCr or other LPS-resistant mice.
| |
INTRODUCTION |
|---|
|
|
|---|
In mice, sensitivity to
lipopolysaccharide (LPS) is determined by a locus on chromosome 4 which
has been designated the Lps gene (36). Mice with
defective Lps genes are highly resistant to the biological
activity of LPS. The LPS-resistant phenotype has been described in
three mouse strains, C57BL/10ScCr (Cr) (5), C3H/HeJ
(30), and C57BL/ScN (37). In addition to these
naturally occurring mutants, a fourth LPS-resistant strain, BALB/c/l,
was produced independently in two laboratories (32, 38) by
backcrossing the defective Lps gene from C3H/HeJ into the
BALB/c background. The LPS-resistant strains are designated
Lpsd (Lps defective), and the
LPS-sensitive strains are designated Lpsn
(Lps normal). Very recently, evidence has been presented
that Lps and Toll-like receptor-4 (Tlr4) genes
are identical. Cr mice were shown to be homozygous for a null mutation
of the Lps/Tlr4 gene, while C3H/HeJ mice carry a missense
mutation of the gene, predicted to replace a proline with a histidine
at position 712 of the Tlr4 polypeptide chain (24). Mice of
all the Lpsd strains mentioned above are, under
normal conditions, highly resistant to all LPS effects. There is,
however, an important difference between the Cr and the C3H/HeJ and
BALB/c/l strains. This concerns their abilities to produce gamma
interferon (IFN-
) in response to microorganisms; the response is
normal in C3H/HeJ and BALB/c/l but highly impaired in Cr mice
(11). As demonstrated in an earlier study, IFN-
is a key
mediator of the LPS hypersensitivity induced by infection (10,
17). Consequently, when C3H/HeJ or BALB/c/l mice are infected or
treated with killed bacteria, they become partial LPS responders, while
Cr mice retain their LPS-resistant phenotype (12).
The defective IFN-
responses of Cr mice have been demonstrated both
in vivo and in vitro by treatment of the mice with live or killed
bacteria or following infection with certain parasites (Plasmodium chabaudi chabaudi and Leishmania
major). Cr mice, however, do not exhibit a general defect in
IFN-
response, since splenocytes of these mice produce high levels
of IFN-
when stimulated with the T-cell mitogen concanavalin A or
with monoclonal antibodies to CD3. The defective IFN-
response of
these mice therefore seems to be confined to IFN-
induced by
microorganisms (11, 21, 40).
Recently, we observed that splenocytes of Cr mice, supplemented with
macrophages of the related, IFN-
-normal C57BL/10ScSn (Sn) mice,
acquire the ability to produce IFN-
in response to gram-negative
bacteria. A similar effect was also achieved with supernatants of Sn
macrophages that had been stimulated with killed gram-negative
bacteria. Such supernatants by themselves do not directly induce
IFN-
in Cr splenocytes; however, they enable these cells to produce
IFN-
in the presence of a bacterial stimulus. The helper factor
present in the active supernatants was identified as IFN-
. This
provided evidence that IFN-
is a cofactor for IFN-
production by
gram-negative bacteria and that it is missing in Cr mice
(40). The reason for the absence of an IFN-
production in
Cr mice, however, remained unclear.
In the present study, we used Cr and BALB/c/l mice and the
corresponding Lpsn mice of the strains Sn and
BALB/c, respectively, to investigate the reason for the absence of
IFN-
production in Cr mice stimulated with gram-negative bacteria.
We show that IFN-
production induced in mice by bacteria is a
function of the LPS component, and therefore the inability of Cr mice
to produce IFN-
after stimulation with bacteria is directly related
to their LPS-resistant phenotype.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Animals. Lpsd C57BL/10ScCr (Cr) and BALB/c/l (32) and Lpsn C57BL/10ScSn (Sn) and BALB/c mouse strains were bred under specific-pathogen-free conditions in the animal facilities of the Max-Planck-Institut für Immunbiologie. Four-week-old mice of either sex were used as donors of bone marrow-derived precursor cells, and 6- to 8-week-old animals were used as donors of splenocytes and for in vivo experiments.
Treatment of mice.
For injection, the agents under test were
dissolved or suspended (bacteria) in pyrogen-free phosphate-buffered
saline (PBS) and administered to mice (0.2 ml/animal) intravenously in
the lateral tail vein. One hour after injection, the mice were
sacrificed under anesthesia, and the spleens were removed and treated
for RNA extraction as described below. The spleen samples were stored at
80°C until they were used.
Macrophages.
Macrophages were cultured from bone marrow
precursor cells of the various mouse strains in the presence of
L-cell-conditioned medium, as previously described (9).
Cells obtained after 10 days of culture were centrifuged, washed twice,
and suspended in serum-free, high-glucose formulations of Dulbecco
modified Eagle medium at a concentration of 106/ml. The
macrophages (3 × 106/well) were placed in six-well
plates (Costar, Cambridge, Mass.) and cultured at 37°C in a
humidified atmosphere containing 8% CO2 for 24 h.
Thereafter, the macrophage supernatants were replaced by fresh medium
and 30 µl of the stimulating agent under test per well was added.
Cultivation then continued for different periods of time. Culture
supernatants for cytokine measurement were collected and stored in
aliquots at
80°C. Total macrophage RNA was extracted as described below.
Materials. The gram-negative bacteria Salmonella enterica serovar Typhimurium (C5), Escherichia coli (J5), Proteus mirabilis, Pseudomonas aeruginosa, Shigella enteritidis, and Vibrio cholerae and the gram-positive Listeria monocytogenes and Staphylococcus aureus were obtained from overnight cultures. Other gram-positive bacteria employed, Lactobacillus bulgaricus and Streptococcus thermophilus, were a kind gift from C. De Simone, University of L'Aquila, L'Aquila, Italy, and Propionibacterium acnes ATCC 12930 was kindly provided by S. Schlecht, Max-Planck-Institut für Immunbiologie, Freiburg, Germany. All bacteria were washed twice with pyrogen-free PBS (pH 7.2) and killed by heating them at 65°C for 1 h. They were subsequently centrifuged, washed twice with pyrogen-free distilled water, and lyophilized. Endotoxin contamination in the gram-positive bacterial preparations was <0.1 pg/mg as determined by the Limulus amoebocyte lysate test (33). For use, the bacteria were suspended in pyrogen-free PBS, pH 7.2.
LPS of Salmonella enterica serovar Abortus equi in its uniform triethylamine salt form was obtained as described earlier (14). A sterile aqueous stock solution (10 mg/ml) was prepared and stored at 4°C. Before use, the LPS was diluted further with pyrogen-free PBS to the desired concentration. Double-stranded RNA [dsRNA; poly(I):poly(C)] was purchased from Boehringer (Mannheim, Germany). Recombinant murine IFN-
was a kind
gift from M. Moriyama (Toray Industries Inc., Tokyo, Japan). Monoclonal
anti-IFN-
(rat immunoglobulin G1) was purchased from Yamasa Shoyu
(Tokyo, Japan), and monoclonal anti-IFN-
(rat immunoglobulin G1) was
purchased from GIBCO BRL (Gaithersburg, Md.).
ELISAs.
For measurement of cytokines in supernatants of
stimulated macrophages, commercial enzyme-linked immunosorbent assay
(ELISA) kits were used. For interleukin 1
(IL-1
), an ELISA kit
was obtained from Genzyme, Cambridge, Mass.; for IL-6 and IL-10, the
kits were from PerSeptive Diagnostics, Cambridge, Mass. The detection
limits of the assays were 0.5 pg/ml for IL-1
, 10 pg/ml for IL-6, and 5 pg/ml for IL-10. IFN-
in supernatants of spleen cell cultures was
estimated by a previously described ELISA (29). The limit of
detection was 75 pg/ml.
Bioassays.
Tumor necrosis factor alpha (TNF-
) in
macrophage supernatants was measured in a cytotoxicity test using a
TNF-
-sensitive L 929 cell line as described earlier (1,
8). The detection limit of the test was 4 pg of TNF-
/ml of supernatant.
was measured in a bioassay described previously
(40). The assay is based on the fact that Cr splenocytes
which produce no IFN-
when stimulated with serovar Typhimurium do so
when exogenous IFN-
is added as a cofactor. The amounts of IFN-
thus induced by a given number of serovar Typhimurium cells is
dependent on the dose of IFN-
added. In this assay, the IFN-
present in macrophage supernatants was determined by comparing the
potency of such supernatants to support an IFN-
response to serovar
Typhimurium in Cr splenocytes with that of standard recombinant murine
IFN-
. Splenocyte suspensions were prepared from the spleens of three
or more mice, pooled, and adjusted to a concentration of 2 × 107/ml of Dulbecco modified Eagle medium. The spleen cells
(100 µl/well) were placed in 96-well plastic plates (Nunc, Roskilde,
Denmark) together with 100 µl of diluted macrophage supernatant or
recombinant murine IFN-
(standard)/well and 10 µl of serovar
Typhimurium cells (20 µg)/well. Cultures containing supernatant of
unstimulated macrophages and cultures without serovar Typhimurium
served as controls. After 24 h of culture at 37°C in a
humidified atmosphere containing 5% CO2, supernatants for
IFN-
measurement were collected and stored frozen at
80°C until
they were used. Inhibition of the IFN-
response by preincubation of
active macrophage supernatants with monoclonal anti-IFN-
(2 µg/100
µl) for 30 min at 4°C was used to verify the IFN-
specificity of
the assay. A similar preincubation with monoclonal anti-IFN-
had no
effect on the IFN-
response. The detection limit of the test was 25 U of IFN-
/ml.
The amount of biologically active IL-1 was measured with human
dermal fibroblasts, as described previously (20). The
detection limit of the assay was 10 pg/ml.
RNA extraction.
Total RNA was isolated from cells and from
spleens by a guanidinium isothiocyanate-phenol-chloroform-isoamyl
alcohol procedure (3). Briefly, live cells or freshly
removed spleens were homogenized in 1.8 ml of solution D (4 M
guanidinium isothiocyanate, 25 mM sodium citrate [pH 7], 0.5%
sarcosyl, and 0.1 M 2-mercaptoethanol) per organ. Subsequently, 1/10 of
the volume of 2 M sodium acetate (pH 4) was added. The homogenates were
stored at
80°C until RNA extraction. Total RNA was extracted from
homogenates with 1 volume of Tris-EDTA-saturated phenol and 1/5
homogenate volume of chloroform-isoamyl alcohol (49:1). RNA was
precipitated from the aqueous phase by the addition of 1 volume of
isopropanol chilled to
20°C. The precipitates were washed twice
with cold 70% ethanol and resuspended in 15 to 20 µl of RNase-free
H2O. The RNA concentration was determined by absorbance at
260 nm.
Northern blot analysis.
RNA samples (2 to 15 µg) were
fractionated on 1.2% denaturing agarose-formaldehyde gels and
transferred to Nytran filters as described previously (18).
The RNAs were hybridized overnight at 65°C with random-primed
32P-labeled cDNA probes as described previously. The
IFN-
probe was a 571-bp cDNA fragment spanning the complete open
reading frame for murine IFN-
(40). The IFN-
probe was
a 581-bp fragment spanning the complete open reading frame for murine
IFN-
4. This fragment was generated by PCR using the primers mmIFNA1
(5'-CACCATGGCTAGGCTCTGT-3') and mmIFNA1R
(5'-CACTTTGTCTCAGGACTCCA-3') and subcloned into Bluescript (Stratagene). The conditions for PCR were 94°C for 30 s, 50°C for 30 s, and 72°C for 30 s for 30 cycles using mouse
genomic DNA as a template. The TNF-
probe was a 1,100-bp cDNA
fragment spanning the complete open reading frame for murine TNF-
,
kindly provided by B. Beutler, Howard Hughes Medical Institute, Dallas, Tex. Under the above-mentioned conditions, in agreement with earlier findings (6, 22) a major TNF-
band (approximately at the position of 18S RNA), and sometimes a second, weaker TNF-
band (below 28S RNA), appeared after hybridization.
mRNA in macrophages stimulated with
dsRNA. The radiolabeled TNF-
probe hybridized with the exogenously added dsRNA present in the total-RNA extracts of macrophages and obscured the TNF-
mRNA signal (see Fig. 1 and 2).
RPA. Cytokine mRNAs were detected by an RNase protection assay (RPA) (15) using a RiboQuant Multi-Probe RPA system (Pharmingen, San Diego, Calif.) as described in the Pharmingen standard protocol. Briefly, the template set (mCK-3b) was used for a T7 RNA polymerase-dependent synthesis of 32P-labeled antisense RNA probes. The RNA samples were hybridized overnight with an excess of labeled probes. After treatment with RNases A and T1 and with proteinase K, the samples were loaded on a 6% polyacrylamide-Tris-borate-EDTA-urea gel and run at 1,900 V with 1× Tris-borate-EDTA electrophoresis buffer, pH 8.3. The gel was dried, and autoradiography film (BIOMAX MS; Kodak, Rochester, N.Y.) was exposed using an intensifying screen (Cronex Lightening Plus; Dupont).
| |
RESULTS |
|---|
|
|
|---|
Kinetics of induction of IFN-
and TNF-
mRNAs by different
stimuli in macrophages.
To determine the time of maximal
expression of IFN-
and TNF-
mRNAs, macrophages of the
Lpsn Sn mice were stimulated with LPS, serovar
Typhimurium, S. aureus, or dsRNA for different periods of
time (up to 24 h). Unstimulated macrophages cultured in parallel
served as a control. Total macrophage RNA was then isolated, and
expression of IFN-
and TNF-
mRNAs was investigated by Northern
blot analysis (Fig. 1). Control
macrophages expressed no IFN-
or TNF-
mRNA at any time point.
Macrophages stimulated with LPS or either of the two bacteria exhibited
a strong expression of TNF-
mRNA after 1 h that remained
detectable for up to 24 h. LPS and bacteria, however, differed in
their potencies to induce IFN-
mRNA. While LPS and the gram-negative
serovar Typhimurium induced a transient expression with a peak at
3 h, the gram-positive S. aureus induced no expression
of IFN-
mRNA. dsRNA was the only stimulus used that was capable of a
strong, long-lasting induction of IFN-
mRNA in Sn macrophages. Due
to technical reasons, the induction of TNF-
mRNA by dsRNA could not
be evaluated (see Materials and Methods). Evidence that dsRNA does
induce TNF-
in macrophages is presented below. The results show that
3 h of stimulation is a good compromise time point for measuring
the induction of all messages, and it was adopted in the following
experiments.
|
Comparative analysis of IFN-
and TNF-
mRNAs induced by
gram-negative and gram-positive bacteria in
Lpsn and Lpsd
macrophages.
Macrophages of Lpsn (Sn and
BALB/c) and Lpsd (Cr and BALB/c/l) mice were
stimulated with gram-negative serovar Typhimurium and E. coli) and gram-positive (S. aureus, P. acnes, and S. thermophilus) bacteria. In addition, LPS
and dsRNA were used as control stimuli. The induction of IFN-
and
TNF-
mRNAs after 3 h of stimulation is shown in Fig.
2. As expected, LPS induced IFN-
and
TNF-
mRNA in macrophages of Lpsn but not
Lpsd mice. Interestingly, while the two
gram-negative bacteria induced TNF-
mRNA in all types of
macrophages, they induced significant amounts of IFN-
mRNA only in
the Lpsn macrophages. Also, the gram-positive
bacteria induced varying amounts of TNF-
mRNA in all types of
macrophages. However, an induction of IFN-
mRNA by gram-positive
bacteria was either undetectable or extremely weak. Thus, in some
cases, after longer exposure times of the autoradiography film very
faint bands of IFN-
mRNA became visible. These were several orders
of magnitude weaker than those induced in Lpsn
macrophages by gram-negative bacteria. Since similar weak bands were
also seen in some of the untreated control macrophages as well as in Cr
macrophages treated with gram-negative bacteria, it cannot be decided
whether such bands represent constitutive IFN-
mRNA expression or
whether they represent a very weak mRNA induction. In separate
experiments in which macrophages of Lpsn and
Lpsd mice were stimulated with L. monocytogenes (300 µg/106 cells), similar results
were obtained (not shown). Both types of macrophages exhibited strong
expression of TNF-
mRNA; however, IFN-
mRNA was not detectable.
On long exposure of the autoradiography film (2 weeks), an extremely
weak IFN-
signal became discernible. As expected, dsRNA was a potent
inducer of IFN-
in all types of macrophages. Again, the inducibility
of TNF-
by dsRNA could not be evaluated for the reasons given in
Materials and Methods. From these results, we conclude that the
induction of IFN-
mRNA by bacteria requires the participation of
LPS. The induction is observed, as a rule, only with gram-negative
bacteria and consequently proceeds only in Lpsn
macrophages.
|
might be produced by macrophages
in response to LPS, bacteria, and dsRNA. All samples investigated in
Fig. 2 were also analyzed by Northern blotting for the presence of
IFN-
mRNA (not shown). However, it was not detectable in any of the
samples, even after prolonged exposure times (up to 6 weeks).
Production of IFN-
and other cytokines by
Lpsn and Lpsd
macrophages stimulated with gram-negative and gram-positive
bacteria.
For the induction of IFN-
, macrophages of the
different mouse strains were stimulated with different gram-negative
and gram-positive bacteria and, in addition, with LPS for 8 h. As
shown in Table 1, IFN-
could not be
detected in unstimulated macrophages. LPS and all gram-negative
bacteria induced varying amounts of IFN-
in Sn and BALB/c but not in
Cr and BALB/c/l macrophages. In contrast, gram-positive bacteria did
not induce IFN-
in either the Lpsn or the
Lpsd macrophages. Therefore, IFN-
production
is induced only by gram-negative bacteria and only in LPS
responder macrophages.
|
, IL-1
, IL-6, and IL-10, macrophages
from the four mouse strains were stimulated with the different bacteria
and LPS, and in addition, with dsRNA for 24 h. Figure 3 shows the results obtained with serovar
Typhimurium, S. aureus, LPS, and dsRNA. Unstimulated
macrophages of all mouse strains exhibited a very low production (10 to
20 pg/ml) of IL-10, while all other cytokines investigated were not
detectable. In general, LPS induced the formation of all of the
above-mentioned cytokines only in Lpsn
macrophages. In contrast, serovar Typhimurium and S. aureus
induced all cytokines tested for in macrophages of all four mouse
strains, regardless of their LPS responsiveness. Additional
gram-negative bacteria tested (E. coli, P. mirabilis, P. aeruginosa, S. enteritidis, and V. cholerae) induced levels of macrophage cytokines
comparable to those induced by serovar Typhimurium (not shown). Other
gram-positive bacteria (P. acnes, S. thermophilus, and L. bulgaricus) induced IL-1
, IL-6,
and IL-10 at levels approximately 10 times lower than those induced by
S. aureus, and in contrast to S. aureus, they
elicited only very low levels of TNF-
(not shown). The presence of
IL-1 measured in supernatants by ELISA was also confirmed in a
bioassay, indicating that this cytokine was present in biologically active form (results not shown).
|
, in
all types of macrophages under investigation (Fig. 3). Thus, although
we could not evaluate the induction of TNF-
mRNA by Northern blot
analysis (see above), dsRNA was a potent inducer of TNF-
in both
Lpsd and Lpsn macrophages.
The results described above indicate that while a number of macrophage
cytokines are inducible by gram-negative and gram-positive bacteria
regardless of whether they contain LPS, the induction of IFN-
by bacteria is dependent mainly on LPS.
In vivo induction of IFN-
, TNF-
, and IL-6 mRNAs in
Lpsn and Lpsd mice
injected with serovar Typhimurium and S. aureus.
Groups of
three mice were injected with heat-killed serovar Typhimurium or
S. aureus (15 µg/g of body weight) intravenously, and
1 h later the animals were sacrificed and their spleens were removed for RNA isolation. The presence of IFN-
, TNF-
, and IL-6 mRNA as analyzed by RPA is shown in Fig.
4. All controls showed a weak
constitutive expression of TNF-
and no expression of IFN-
or IL-6
mRNA. Both bacteria induced strong TNF-
and IL-6 mRNA responses in
all mouse strains used. IFN-
mRNA, however, was inducible only by
the gram-negative serovar Typhimurium and only in
Lpsn mice. An IFN-
response to S. aureus was absent in all mouse strains. As expected, LPS
administered to the mice in vivo induced IFN-
, TNF-
, and IL-6
mRNAs only in Lpsn mice (results not shown).
|
| |
DISCUSSION |
|---|
|
|
|---|
One interesting biological activity of IFN-
that we
described earlier (40), and which has subsequently been
confirmed by other studies (16, 25), is its property of
acting as a cofactor in the induction of IFN-
. It was also shown
that gram-negative bacteria induce IFN-
in the
Lpsn Sn mice but not in the related
Lpsd Cr mice (40). This finding was
unexpected, because bacteria (gram negative and gram positive)
generally induce different cytokines in both
Lpsn and Lpsd mice
(7, 8, 19). We investigated the reason for the
above-mentioned inability of Cr mice to produce IFN-
by comparing
their IFN-
and other macrophage cytokine responses to those of
Lpsd BALB/c/l and Lpsn Sn
and BALB/c mice following stimulation with different gram-negative and
gram-positive bacteria.
IFN-
mRNA and IFN-
activity were inducible by LPS and by a large
number of gram-negative bacteria in macrophages of
Lpsn mice (Sn and BALB/c) cultured in vitro.
Further, IFN-
mRNA was detectable in both
Lpsn strains of mice injected with LPS or
serovar Typhimurium. In contrast, neither LPS nor gram-negative
bacteria induced IFN-
in Lpsd mice that was
in any way comparable to that seen in Lpsn mice.
Thus, in BALB/c/l mice IFN-
mRNA was practically undetectable and in
Cr mice only extremely weak bands were visible after long exposure.
Gram-positive bacteria induced no IFN-
activity in any of the mice,
regardless of their LPS sensitivity, and in only some cases a very weak
IFN-
mRNA signal was recognizable after prolonged exposure of the
autoradiography film. All bacteria, however, induced comparable amounts
of TNF-
, IL-1
, IL-6, and IL-10 in vitro or in vivo in
Lpsn and Lpsd mice. Thus,
while macrophage cytokines known to be induced by LPS are also
inducible by all bacteria in Lpsn and
Lpsd mice, IFN-
is an exception, being
inducible practically only by LPS and therefore generally by
gram-negative microorganisms. The inability of Cr and BALB/c/l mice to
produce significant amounts of IFN-
when stimulated by gram-negative
bacteria is, therefore, related to their lack of LPS responsiveness. A
similar absence of IFN-
response to bacteria is predicted for the
C3H/HeJ and C57BL/10ScN Lpsd mice (not
investigated here). Therefore, LPS emerges as the only notable
bacterial component capable of inducing IFN-
, and gram-positive bacteria emerge as a class of microorganisms that are practically incapable of inducing this cytokine.
Recently, evidence has been accumulating that the induction of
cytokines by bacterial components is effected via Toll-like receptors
(Tlr) 2 and 4 acting as signaling molecules (2, 4, 24, 26, 28, 42,
43). In the present study, the induction of IFN-
and other
cytokines by LPS in normal mice and its complete absence in
Tlr4/Lps-defective mice (Cr and BALB/c/l) is evidence that
LPS signal transduction proceeded solely via Tlr4. Further, the
cytokine responses to bacteria obtained in the absence of LPS
signaling, i.e., those induced by gram-positive bacteria or by
gram-negative bacteria in Cr and BALB/c/l mice, must proceed via Tlr2
(and/or by as-yet-unidentified signaling receptors). Since IFN-
is
selectively absent from such responses, it may be concluded that in
mice the induction of IFN-
is strictly Tlr4 dependent, while the
induction of other cytokines by LPS or other bacterial components can
proceed by the Tlr4 or Tlr2 signaling pathway, respectively.
It has been shown that IFN-
is the predominant type I interferon
induced in mice by LPS (39). IFN-
and IFN-
share the same cellular receptor, which explains their similar biological activities (23). In this connection, we have shown that both type I IFNs act as cofactors of IFN-
induction (40). We
also investigated the possibility of IFN-
being produced as an
alternative to IFN-
but could obtain no evidence for its presence,
either on Northern blots or in supernatants from stimulated
macrophages, using a bioassay. Interestingly, synthetic
oligodeoxynucleotides containing unmethylated CpG motifs from bacterial
DNA and nucleic acid fraction from Mycobacterium bovis BCG
have been shown to induce IFN-
/
(31, 34, 41).
Therefore, the absence of detectable IFN-
/
activity in
Lpsn and Lpsd mice
stimulated with different gram-positive bacteria and also in
Lpsd mice stimulated with gram-negative bacteria
observed in our study was surprising. It raises the question of how
much of the bacterial DNA is really available for bioactivity in
bacterium-treated mice.
As mentioned above, IFN-
acts as a cofactor in the induction of
IFN-
. The present results also allow further conclusions to be made
regarding IFN-
induction by bacteria. Since LPS is the only
bacterial component inducing significant amounts of IFN-
, it follows
that generally only gram-negative bacteria induce IFN-
via the
IFN-
-dependent pathway. An IFN-
-dependent production of IFN-
is therefore absent from the LPS-resistant Cr and BALB/c/l mice.
BALB/c/l mice, however, produce IFN-
in response to gram-negative bacteria, indicating that these bacteria induce IFN-
by additional, IFN-
-independent mechanisms. The latter pathway is also utilized very efficiently by gram-positive bacteria, since many of these bacteria are known to be excellent inducers of IFN-
. Therefore, the
inability of Cr mice to produce IFN-
in response to any bacteria is
related not only to the absence of IFN-
but also to a general inability to respond to the array of IFN-
-inducing components present in bacteria and, as shown in earlier studies, also in parasites, such as P. chabaudi chabaudi (11) and
L. major (21). It is interesting that when
exogenous IFN-
is administered to Cr mice, they acquire the ability
to produce IFN-
after stimulation with gram-negative (reference
40 and this study) but not gram-positive (unpublished data) bacteria. This indicates that the IFN-
-dependent pathway of IFN-
induction is intact in these mice and that this pathway is utilized only by gram-negative bacteria.
Type I interferons are strongly inducible by viruses and play an
important role in antiviral defence (23, 27, 35).
Consequently, they have been investigated most extensively in this
connection. The significance of IFN-
or IFN-
in bacterial
infections has been much less studied. It has been shown that mice
deficient for the IFN-
/
receptor are indistinguishable from
wild-type mice in their susceptibility to L. monocytogenes
infection (35). In view of the present results, the
above-mentioned investigation allows no conclusions to be made
regarding the significance of IFN-
/
in this infection model,
since L. monocytogenes induces no IFN-
/
and it would
make no difference if the mice are deficient for the IFN-
/
receptor or not. In our hands, administration of exogenous recombinant
murine IFN-
to mice infected with serovar Typhimurium had no
detectable protective effect (M. Matsuura and C. Galanos, unpublished
data). This may be understandable, considering that IFN-
is already
induced during serovar Typhimurium infection and additional exogenous
IFN-
may have no further discernible effect. For this reason, any
antibacterial effect of exogenously administered IFN-
might be best
recognized during infections by gram-positive bacteria, since these do
not induce this cytokine. In this connection, it is interesting that a
protective effect of exogenously administered IFN-
has been reported
in the case of infection with L. monocytogenes
(13). For future investigations of the role of IFN-
/
in infections by gram-negative bacteria, new models will have to be
developed. Of special interest would be the use of IFN-
/
receptor-deficient mice.
| |
ACKNOWLEDGMENTS |
|---|
We are indebted to N. Goos and H. Stübig for excellent technical assistance and U. Müller for his help in the preparation of the manuscript.
This work was supported in part by BMBF-Gesundheit, projekt O1KI9854/8.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Max-Planck-Institut für Immunbiologie, Stübeweg 51, D-79108 Freiburg, Germany. Phone: 49-761-5108-404. Fax: 49-761-5108-403. E-mail: freudenberg{at}immunbio.mpg.de.
Present address: Max-von-Pettenkofer-Institut für
Mikrobiologie und Hygiene, Abt. Bakteriologie, D-80336 Munich, Germany.
Present address: Novartis Pharma AG, Biotechnology,
S-506.3.14, CH-4002 Basel, Switzerland.
Editor: R. N. Moore
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Aggarwal, B. B.,
W. J. Kohr,
P. E. Hass,
B. Moffat,
S. A. Spencer,
W. J. Henzel,
T. S. Bringman,
G. E. Nedwin,
D. V. Goeddel, and R. N. Harkins.
1985.
Human tumor necrosis factor. Production, purification, and characterization.
J. Biol. Chem.
260:2345-2354 |
| 2. |
Brightbill, H. D.,
D. H. Libraty,
S. R. Krutzik,
R. B. Yang,
J. T. Belisle,
J. R. Bleharski,
M. Maitland,
M. V. Norgard,
S. E. Plevy,
S. T. Smale,
P. J. Brennan,
B. R. Bloom,
P. J. Godowski, and R. L. Modlin.
1999.
Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors.
Science
285:732-736 |
| 3. | Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159[Medline]. |
| 4. |
Chow, J. C.,
D. W. Young,
D. T. Golenbock,
W. J. Christ, and F. Gusovsky.
1999.
Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction.
J. Biol. Chem.
274:10689-10692 |
| 5. | Coutinho, A., and T. Meo. 1978. Genetic bases for unresponsiveness to lipopolysaccharide in C57BL/10Cr mice. Immunogenetics 7:17-24. |
| 6. | De, S. K., H. L. Chen, J. L. Pace, J. S. Hunt, P. F. Terranova, and G. C. Enders. 1993. Expression of tumor necrosis factor-alpha in mouse spermatogenic cells. Endocrinology 133:389-396[Abstract]. |
| 7. |
Dong, Z.,
X. Qi, and I. J. Fidler.
1993.
Tyrosine phosphorylation of mitogen-activated protein kinases is necessary for activation of murine macrophages by natural and synthetic bacterial products.
J. Exp. Med.
177:1071-1077 |
| 8. |
Freudenberg, M. A., and C. Galanos.
1991.
Tumor necrosis factor alpha mediates lethal activity of killed gram-negative and gram-positive bacteria in D-galactosamine-treated mice.
Infect. Immun.
59:2110-2115 |
| 9. |
Freudenberg, M. A.,
D. Keppler, and C. Galanos.
1986.
Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin.
Infect. Immun.
51:891-895 |
| 10. | Freudenberg, M. A., M. Kopf, and C. Galanos. 1996. Lipopolysaccharide-sensitivity of interferon-g-receptor deficient mice. J. Endotox. Res. 3:291-295. |
| 11. |
Freudenberg, M. A.,
Y. Kumazawa,
S. Meding,
J. Langhorne, and C. Galanos.
1991.
Gamma interferon production in endotoxin-responder and -nonresponder mice during infection.
Infect. Immun.
59:3484-3491 |
| 12. | Freudenberg, M. A., R. Salomao, A. Sing, I. Mitov, and C. Galanos. 1998. Reconciling the concepts of endotoxin sensitization and tolerance. Proceedings of the 4th Conference of the International Endotoxin Society. Prog. Clin. Biol. Res. 397:261-268[Medline]. |
| 13. |
Fujiki, T., and A. Tanaka.
1988.
Antibacterial activity of recombinant murine beta interferon.
Infect. Immun.
56:548-551 |
| 14. | Galanos, C., O. Lüderitz, and O. Westphal. 1979. Preparation and properties of a standardized lipopolysaccharide from Salmonella abortus equi (Novo-Pyrexal). Zentbl. Bakteriol. Orig. A 243:226-244. |
| 15. | Gilman, M. 1993. Ribonuclease protection assay, p. 4.7.1-4.7.8. In F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Stuhl (ed.), Current protocols in molecular biology, vol. 1. John Wiley and Sons, Inc., New York, N.Y. |
| 16. | Hunter, C. A., K. E. Gabriel, T. Radzanowski, L. E. Neyer, and J. S. Remington. 1997. Type I interferons enhance production of IFN-gamma by NK cells. Immunol. Lett. 59:1-5[CrossRef][Medline]. |
| 17. |
Katschinski, T.,
C. Galanos,
A. Coumbos, and M. A. Freudenberg.
1992.
Gamma interferon mediates Propionibacterium acnes-induced hypersensitivity to lipopolysaccharide in mice.
Infect. Immun.
60:1994-2001 |
| 18. | Knopf, H. P., F. Otto, R. Engelhardt, M. A. Freudenberg, C. Galanos, F. Herrmann, and R. R. Schumann. 1994. Discordant adaptation of human peritoneal macrophages to stimulation by lipopolysaccharide and the synthetic lipid A analogue SDZ MRL 953. Down-regulation of TNF-alpha and IL-6 is paralleled by an up-regulation of IL-1 beta and granulocyte colony-stimulating factor expression. J. Immunol. 153:287-299[Abstract]. |
| 19. |
Linder, H.,
I. Engberg,
H. Hoschutzky,
I. Mattsby-Baltzer, and C. Svanborg.
1991.
Adhesion-dependent activation of mucosal interleukin-6 production.
Infect. Immun.
59:4357-4362 |
| 20. | Loppnow, H., H. D. Flad, I. Durrbaum, J. Musehold, R. Fetting, A. J. Ulmer, H. Herzbeck, and E. Brandt. 1989. Detection of interleukin 1 with human dermal fibroblasts. Immunobiology 179:283-291[Medline]. |
| 21. | Müller, I., M. Freudenberg, P. Kropf, A. F. Kiderlen, and C. Galanos. 1997. Leishmania major infection in C57BL/10 mice differing at the Lps locus: a new non-healing phenotype. Med. Microbiol. Immunol. 186:75-81[CrossRef][Medline]. |
| 22. |
Pennica, D.,
J. S. Hayflick,
T. S. Bringman,
M. A. Palladino, and D. V. Goeddel.
1985.
Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor.
Proc. Natl. Acad. Sci. USA
82:6060-6064 |
| 23. | Pestka, S., J. A. Langer, K. C. Zoon, and C. E. Samuel. 1987. Interferons and their actions. Annu. Rev. Biochem. 56:727-777[CrossRef][Medline]. |
| 24. |
Poltorak, A.,
X. He,
I. Smirnova,
M. Y. Liu,
C. V. Huffel,
X. Du,
D. Birdwell,
E. Alejos,
M. Silva,
C. Galanos,
M. Freudenberg,
P. Ricciardi-Castagnoli,
B. Layton, and B. Beutler.
1998.
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.
Science
282:2085-2088 |
| 25. |
Sareneva, T.,
S. Matikainen,
M. Kurimoto, and I. Julkunen.
1998.
Influenza A virus-induced IFN-alpha/beta and IL-18 synergistically enhance IFN-gamma gene expression in human T cells.
J. Immunol.
160:6032-6038 |
| 26. |
Schwandner, R.,
R. Dziarski,
H. Wesche,
M. Rothe, and C. J. Kirschning.
1999.
Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2.
J. Biol. Chem.
274:17406-17409 |
| 27. | Sen, G. C., and R. M. Ransohoff. 1993. Interferon-induced antiviral actions and their regulation. Adv. Virus Res. 42:57-102[Medline]. |
| 28. |
Shimazu, R.,
S. Akashi,
H. Ogata,
Y. Nagai,
K. Fukudome,
K. Miyake, and M. Kimoto.
1999.
MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4.
J. Exp. Med.
189:1777-1782 |
| 29. | Slade, S. J., and J. Langhorne. 1989. Production of interferon-gamma during infection of mice with Plasmodium chabaudi chabaudi. Immunobiology 179:353-365[Medline]. |
| 30. |
Sultzer, B. M.
1972.
Genetic control of host responses to endotoxin.
Infect. Immun.
5:107-113 |
| 31. |
Sun, S.,
X. Zhang,
D. F. Tough, and J. Sprent.
1998.
Type I interferon-mediated stimulation of T cells by CpG DNA.
J. Exp. Med.
188:2335-2342 |
| 32. | Takakuwa, T., H. P. Knopf, A. Sing, R. Carsetti, C. Galanos, and M. A. Freudenberg. 1996. Induction of CD14 expression in Lpsn, Lpsd and tumor necrosis factor receptor-deficient mice. Eur. J. Immunol. 26:2686-2692[Medline]. |
| 33. |
Tanamoto, K.,
U. Zähringer,
G. R. McKenzie,
C. Galanos,
E. T. Rietschel,
O. Lüderitz,
S. Kusumoto, and T. Shiba.
1984.
Biological activities of synthetic lipid A analogs: pyrogenicity, lethal toxicity, anticomplement activity, and induction of gelation of Limulus amoebocyte lysate.
Infect. Immun.
44:421-426 |
| 34. | Tokunaga, T., O. Yano, E. Kuramoto, Y. Kimura, T. Yamamoto, T. Kataoka, and S. Yamamoto. 1992. Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate natural killer cells. Microbiol. Immunol. 36:55-66[Medline]. |
| 35. | van den Broek, M. F., U. Müller, S. Huang, M. Aguet, and R. M. Zinkernagel. 1995. Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. J. Virol. 69:4792-4796[Abstract]. |
| 36. | Vogel, S. N. 1992. The Lps gene, p. 485-513. In B. Beutler (ed.), Tumor necrosis factors: the molecules and their emerging role in medicine. Raven Press, New York, N.Y. |
| 37. |
Vogel, S. N.,
C. T. Hansen, and D. L. Rosenstreich.
1979.
Characterization of a congenitally LPS-resistant, athymic mouse strain.
J. Immunol.
122:619-622 |
| 38. |
Vogel, S. N.,
J. S. Wax,
P. Y. Perera,
C. Padlan,
M. Potter, and B. A. Mock.
1994.
Construction of a BALB/c congenic mouse, C.C3H-Lpsd, that expresses the Lpsd allele: analysis of chromosome 4 markers surrounding the Lps gene.
Infect. Immun.
62:4454-4459 |
| 39. | Vogel, S. N., L. L. Weedon, L. M. Wahl, and D. L. Rosenstreich. 1982. BCG-induced enhancement of endotoxin sensitivity in C3H/HeJ mice. II. T cell modulation of macrophage sensitivity to LPS in vitro. Immunobiology 160:479-493[Medline]. |
| 40. |
Yaegashi, Y.,
P. Nielsen,
A. Sing,
C. Galanos, and M. A. Freudenberg.
1995.
Interferon beta, a cofactor in the interferon gamma production induced by gram-negative bacteria in mice.
J. Exp. Med.
181:953-960 |
| 41. | Yamamoto, S., E. Kuramoto, S. Shimada, and T. Tokunaga. 1988. In vitro augmentation of natural killer cell activity and production of interferon-alpha/beta and -gamma with deoxyribonucleic acid fraction from Mycobacterium bovis BCG. Jpn. J. Cancer Res. 79:866-873[CrossRef][Medline]. |
| 42. | Yang, R. B., M. R. Mark, A. Gray, A. Huang, M. H. Xie, M. Zhang, A. Goddard, W. I. Wood, A. L. Gurney, and P. J. Godowski. 1998. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395:284-288[CrossRef][Medline]. |
| 43. |
Yoshimura, A.,
E. Lien,
R. R. Ingalls,
E. Tuomanen,
R. Dziarski, and D. Golenbock.
1999.
Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2.
J. Immunol.
163:1-5 |
This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||